Brief: Lineage Establishes Exclusive Worldwide Collaboration With Genentech

Lineage Cell Therapeutics

20/12/2021 11:30

Dec 20 (Reuters) - Lineage Cell Therapeutics Inc  LCTX.A :
    * LINEAGE ESTABLISHES EXCLUSIVE WORLDWIDE COLLABORATION WITH
GENENTECH FOR THE DEVELOPMENT AND COMMERCIALIZATION OF OPREGEN®
RPE CELL THERAPY FOR THE TREATMENT OF OCULAR DISORDERS
    * LINEAGE CELL THERAPEUTICS INC - GENENTECH WILL PAY LINEAGE
$50
MILLION UPFRONT
    * LINEAGE CELL THERAPEUTICS INC - ELIGIBLE TO RECEIVE A
TOTAL OF
$670 MILLION IN UPFRONT AND MILESTONE PAYMENTS
    * LINEAGE CELL THERAPEUTICS - CO, ITS UNIT, CELL CURE
NEUROSCIENCES, ENTERED INTO EXCLUSIVE COLLABORATION, LICENSE
AGREEMENT WITH ROCHE AND GENENTECH

Source text for Eikon:  ID:nBw5CnJwJa 
Further company coverage:  LCTX.A